https://www.selleckchem.com/pr....oducts/apr-246-prima
69, 95% CI 0.53-0.84). This is the first study examining and comparing plasma α-synuclein levels in ET vs. PD and controls. Preliminary findings suggest that plasma α-synuclein levels might help to discriminate de novo and advanced PD from controls and ET. This is the first study examining and comparing plasma α-synuclein levels in ET vs. PD and controls. Preliminary findings suggest that plasma α-synuclein levels might help to discriminate de novo and advanced PD from controls and ET.Almost all patients with breast cancer wi
Like
Comment
Share
